Ensol Biosciences Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2017	FY 2016	FY 2015
Period Ending	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Cash & Equivalents	721.34	2,921	6,064
Short-Term Investments	1,901	4,159	1,501
Cash & Short-Term Investments	2,622	7,080	7,565
Cash Growth	-62.96%	-6.42%	-
Accounts Receivable	48.61	-	26.28
Other Receivables	5.73	40.11	7.71
Receivables	104.34	40.11	33.99
Prepaid Expenses	36.4	70.03	27.59
Other Current Assets	87.19	106.49	82
Total Current Assets	2,850	7,297	7,709
Property, Plant & Equipment	4,249	4,447	4,636
Long-Term Investments	-	-	0
Other Intangible Assets	128.12	104.58	127.59
Long-Term Deferred Charges	-	266.16	126.5
Other Long-Term Assets	393.9	747.7	406.63
Total Assets	7,621	12,912	13,056
Accrued Expenses	202.38	100.62	89.1
Short-Term Debt	30	-	1,680
Current Portion of Long-Term Debt	-	-	180
Other Current Liabilities	83.99	467.63	84.47
Total Current Liabilities	316.36	568.25	2,034
Other Long-Term Liabilities	32.5	24.13	61.57
Total Liabilities	1,057	1,202	2,581
Common Stock	4,198	4,198	2,021
Additional Paid-In Capital	31,149	31,149	26,340
Retained Earnings	-29,453	-24,032	-17,934
Comprehensive Income & Other	670.39	395.47	47.76
Shareholders' Equity	6,564	11,710	10,475
Total Liabilities & Equity	7,621	12,912	13,056
Total Debt	30	-	1,860
Net Cash (Debt)	2,592	7,080	5,705
Net Cash Growth	-63.39%	24.09%	-
Net Cash Per Share	308.93	858.84	849.11
Filing Date Shares Outstanding	8.39	8.24	6.72
Total Common Shares Outstanding	8.39	8.24	6.72
Working Capital	2,534	6,728	5,675
Book Value Per Share	782.26	1420.48	1558.92
Tangible Book Value	6,436	11,605	10,347
Tangible Book Value Per Share	767.00	1407.79	1539.93
Land	615.31	615.31	615.31
Buildings	3,582	3,582	3,582
Machinery	642.34	538.96	428.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.